H.R. 19 · 117th Congress
Lower Costs, More Cures Act of 2021
- Stage
- In committee
- Sponsor
- Cathy McMorris Rodgers
- Introduced
- 2021-04-21
- Latest action
- 2021-10-19 · Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Subjects
Appropriations
Executive agency funding and structure
Medicare
Administrative law and regulatory procedures
Congressional oversight
Health care costs and insurance
Health care coverage and access
Public contracts and procurement
Government studies and investigations
Health
Health information and medical records
Health promotion and preventive care
User charges and fees
Civil actions and liability
Income tax exclusion
Medicaid
State and local government operations
Inflation and prices
Health care quality
Medical research
Digestive and metabolic diseases
Health programs administration and funding
Drug therapy
Health facilities and institutions
Home and outpatient care
Department of Health and Human Services
Health technology, devices, supplies
Health personnel
Trade agreements and negotiations
Research and development
Government information and archives
Consumer affairs
Chemistry
Intellectual property
Medical education
Prescription drugs
Marketing and advertising
Retail and wholesale trades
Competition and antitrust
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Business records
Manufacturing
Accounting and auditing
Hospital care
Administrative remedies
Judicial review and appeals
Office of the U.S. Trade Representative
Federal Trade Commission (FTC)
Biological and life sciences